Fenbendazole is one of the most talked-about topics in cancer communities heading into 2026 — and we’re adding our voice to the conversation. Watch our latest video where we share our take on FBZ, then grab our free downloadable dosage guideline to keep on hand.
Tag: wellness
The Anticancer Research Expression of Concern: Data Verifiability, Statistical Reliability, and Ethical Oversight Questions Selling the Product Studied? The Wellness Company’s Commercial Role Explained
The article discusses an Expression of Concern issued by Anticancer Research regarding the Hulscher et al. study on ivermectin and mebendazole. It highlights data verifiability issues, the authors’ conflicts of interest tied to The Wellness Company, and how this study differs from credible cancer research, ultimately urging caution for patients evaluating such claims.
What Oncologists and Evidence-Based Medicine Say About Ivermectin for Cancer Right Now
Courage Against Cancer clarifies that ivermectin lacks validated clinical evidence as a cancer treatment despite preclinical interest. Major oncology institutions do not endorse it, emphasizing the importance of rigorous evidence-based evaluations. Patients are encouraged to discuss concerns with their oncologists and critically assess claims surrounding off-label treatments.
The Joe Tippens Story: How a Veterinary Dewormer Became a Viral Cancer Cure Claim
The article from Courage Against Cancer discusses Joe Tippens, whose recovery from small cell lung cancer was linked to fenbendazole, a veterinary dewormer. It emphasizes that his case lacks clinical validation and critical context, such as concurrent immunotherapy, highlighting the importance of distinguishing personal narratives from scientific evidence in cancer treatment discussions.
Breaking Down the Study Design: Why Observational and Self-Reported Data Have Serious Limits
Courage Against Cancer critiques the methodology of the Hulscher et al. study on cancer treatment, emphasizing the weaknesses of observational design and self-reported outcomes. It highlights issues like lack of randomization, potential bias, and conflicts of interest, stressing that results cannot reliably inform clinical decisions and urging patients to consult oncologists about research before acting.
Why did Anticancer Research publish an expression of concern about the 2026 ivermectin study on June 1, 2026?
On June 1, 2026, Anticancer Research issued an Expression of Concern regarding Hulscher et al.’s study on ivermectin-mebendazole, citing issues with data verifiability, statistical reliability, and ethical oversight. The study’s self-reported outcomes and lack of independent monitoring raised further doubts, necessitating independent scrutiny before clinical application.
Direct Answer Cancer treatments like chemotherapy, radiation, and immunotherapy can cause various side effects ranging from mild to severe. Common effects include fatigue, nausea, hair loss, and infection risk. Side effects vary greatly depending on treatment type, dosage, and individual factors. Your medical team can help manage symptoms and improve quality of life during treatment.
Courage Against Cancer emphasizes the integration of genomic sequencing and microbiome testing to enhance cancer treatment strategies. Research indicates that the tumor microenvironment, influenced by gut microbiota, plays a crucial role in cancer behavior and treatment response, particularly in colorectal, breast, and lung cancers, advocating for personalized recovery plans.
Immunotherapy and traditional treatments (surgery, chemotherapy, radiation) each have strengths. The “most effective” option depends on cancer type, stage, and individual factors. Many patients benefit from combinations of both newer and traditional approaches tailored to their specific situation. C
Genomic sequencing is a pivotal innovation in cancer care, providing insights into the genetic changes driving cancer. This technique analyzes cancer cell DNA to identify mutations, guiding personalized treatment and recovery strategies. It empowers patients by enhancing understanding and encourages informed decisions, integrating both conventional and complementary approaches to cancer management.
